Author Question: A client is emerging from anesthesia following ECT. The client is agitated and incoherent. The nurse ... (Read 43 times)

Frost2351

  • Hero Member
  • *****
  • Posts: 557
A client is emerging from anesthesia following ECT. The client is agitated and incoherent. The nurse may expect to administer which medication to stabilize these symptoms?
 
  A) Diazepam
  B) Brevital
  C) Robinul
  D) Caffeine

Question 2

You are working with a 56-year-old female who is a candidate for ECT. The client states, I would think about doing this ECT, but I heard that I won't remember anything after I wake up, and that scares me very much.
 
  The most therapeutic nursing response to the client's statement is what?
 
  A) Don't worry; you will be just fine after ECT. Lots of people are afraid of losing their memory, but it's not really a problem.
  B) Who told you that? It's not really much of an issue with ECT. Sometimes people do lose some of their memory, but it is not a long-term problem.
  C) I hear what you are saying. What is it that makes you so afraid of losing your memory?
  D) I understand your concern. You may experience some short-term memory loss right after the procedure, but it is not a long-term effect.



macagnavarro

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Ans: A
When postictal agitation occurs, the client may require intravenous diazepam (Valium). During the ECT procedure, the client is given a quick-acting anesthetic, such as Brevital, after being placed on a padded mat or table. An atropine-like drug, Robinul, is given to dry up body secretions and prevent aspiration. Caffeine would be an inappropriate drug to give this patient for these symptoms.

Answer to Question 2

Ans: D
The correct answer provides empathy for the client's concerns, followed by patient teaching about the effects of ECT. Memory loss after ECT is usually short term, with a return to normal function in a few days or weeks.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

For a complete list of videos, visit our video library